Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 1998

View Archived Issues

Connetics: Q4 and FY 1997 highlights

Life Medical Sciences updates shareholders

Inhale Therapeutic Systems: Q4 and FY 1997 highlights

New agents for IBS from Nippon Shinyaku

Novel mitomycin C derivative reported by Sagami

Potent and safe new quinolones from Daiichi

New implant for delivery of LHRH agonists

Novel compound MK6059 isolated by Meiji Seika/Mitsubishi Chemical

Wyeth-Ayerst describes synthesis and pharmacological profile of new agent for stroke

PLA2 inhibitors --BM-16.2115, mepacrine and manoalide-- reduce human leukocyte chemotaxis

Institute of Microbial Chemistry discovers new antibacterial/cytotoxic antibiotic

SGLT inhibitors under evaluation at Tanabe as antidiabetic agents

Antibradycardic M2 receptor antagonists prepared at Yamanouchi

Warning issued for Duract related to potential hepatotoxicity

Safety warnings issued by FDA for Hismanal

Idec evaluates humanized anti-gp39 antibody in phase I

GeneMedicine and Corange progress in cancer alliance

Lilly describes second-generation NK1 antagonist

New antiinflammatory agents prepared by Brazilian academics

Vorozole safe and effective in phase II EORTC study

Preclinical profile of S-4661, a new carbapenem, characterized

Macritonin clinical trial update

Topoisomerase I inhibitor tested in phase I trial

Two combinations compared for treatment of multidrug-resistant falciparum malaria

Targeted Genetics to report tgDCC-E1A clinical data

Anti-Candida activity of voriconazole compared to other antifungal agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...